STRR
Star Equity Holdings, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$11.15-0.09%
Price as of Jul 20, 2026
STRR financials
Star Equity Holdings, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $172.2M | $53.4M | $161.3M | $112.2M |
| Cost of revenue | $93.5M | $42.3M | $81.1M | $86.3M |
| Gross profit | $78.7M | $11.1M | $80.3M | $25.9M |
| Operating expenses | $82.3M | $19.5M | $78.9M | $29.0M |
| Operating income | -$3.7M | -$8.4M | $1.4M | -$3.1M |
| Net income | -$5.9M | -$10.4M | $2.2M | -$5.3M |
| EBITDA | -$2.6M | -$6.6M | $4.0M | -$9.0K |
| Basic EPS | $-2.08 | $-3.97 | $-1.11 | $-1.27 |
| Diluted EPS | $-2.08 | $-3.97 | $-1.11 | $-1.27 |
| Balance sheet | ||||
| Cash & equivalents | $12.1M | $17.0M | $22.6M | $27.1M |
| Total assets | $113.2M | $52.6M | $61.0M | $67.9M |
| Total liabilities | $47.5M | $12.2M | $12.4M | $22.1M |
| Stockholders’ equity | $65.7M | $40.4M | $48.6M | $45.8M |
| Total debt | $26.4M | $1.1M | $1.4M | $1.9M |
| Net debt | $14.3M | -$15.9M | -$21.2M | -$25.2M |
| Cash flow | ||||
| Operating cash flow | -$7.3M | -$5.2M | $2.7M | -$3.9M |
| Capital expenditure | -$1.7M | -$2.9M | -$698.0K | -$1.2M |
| Free cash flow | -$9.0M | -$8.0M | $2.0M | -$5.0M |
| Dividends paid | -$740.0K | -$2.0M | -$1.9M | -$1.9M |
| Share repurchases | -$2.6M | -$279.0K | $0.00 | -$5.0K |